相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia
Susan M. O'Brien et al.
BLOOD (2009)
Immunosensitization with a Bcl-2 small molecule inhibitor
Jonathan Begley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway
Zhiwei Wang et al.
CANCER RESEARCH (2009)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
Shengbing Huang et al.
CLINICAL CANCER RESEARCH (2009)
A global transcriptional view of apoptosis in human T-cell activation
Min Wang et al.
BMC MEDICAL GENOMICS (2008)
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
Marina Konopleva et al.
CANCER RESEARCH (2008)
Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses
Elizabeth K. Wansley et al.
CLINICAL CANCER RESEARCH (2008)
A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies
Aaron D. Schimmer et al.
CLINICAL CANCER RESEARCH (2008)
Combination of docetaxel and recombinant vaccine enhances T-Cell responses and antitumor activity: Effects of docetaxel on immune enhancement
Charlie T. Garnett et al.
CLINICAL CANCER RESEARCH (2008)
Paradigm shifts in cancer vaccine therapy
Jeffrey Schlom et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis
Justin L. Mott et al.
MOLECULAR CANCER THERAPEUTICS (2008)
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells
P. Perez-Galan et al.
LEUKEMIA (2008)
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
Jiannong Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Novel agents in chronic lymphocytic leukemia: Efficacy and tolerability of new therapies
Thomas S. Lin
CLINICAL LYMPHOMA & MYELOMA (2008)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
Mai Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Anticancer and immunosuppressive properties of bacterial prodiginines
Neil R. Williamson et al.
FUTURE MICROBIOLOGY (2007)
Enhancing efficacy of therapeutic vaccinations by combination with other modalities
James L. Gulley et al.
VACCINE (2007)
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Suzanne Trudel et al.
BLOOD (2007)
Phase I trial of an enhanced prostate-specific antigen-based vaccine and Anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer
Marc R. Theoret et al.
CLINICAL GENITOURINARY CANCER (2007)
Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells
Clara Campas et al.
EXPERIMENTAL HEMATOLOGY (2006)
Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer
PM Arlen et al.
JOURNAL OF UROLOGY (2005)
The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors
C Kudo-Saito et al.
CLINICAL CANCER RESEARCH (2005)
Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules
KY Tsang et al.
CLINICAL CANCER RESEARCH (2005)
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
JT Opferman et al.
NATURE (2003)
Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen-presenting cells in regional lymph nodes
E Kass et al.
CYTOKINE (2000)
分享论文
